16 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Deciphera Pharmaceuticals, Inc. DCPH stock surged 123.1% to $44.50 during Tuesday's pre-market session. The market value of their outstanding shares is at $844.5 million. The most recent rating by Deutsche Bank, on July 18, is at Buy, with a price target of $42.00.
• Cellect Biotechnology, Inc. APOP stock increased by 5.0% to $0.61. The market cap seems to be at $1.6 million.
• Akers Biosciences, Inc. AKER shares surged 4.4% to $0.49. The market value of their outstanding shares is at $5.2 million.
• Pfizer, Inc. PFE shares surged 4.2% to $36.87. The market value of their outstanding shares is at $205.4 billion. According to the most recent rating by Morgan Stanley, on July 30, the current rating is at Equal-Weight.
• Vical, Inc. VICL shares moved upwards by 4.1% to $0.83. The market cap stands at $16.2 million.
• Elanco Animal Health, Inc. ELAN shares surged 3.4% to $30.75. The market value of their outstanding shares is at $11.6 billion. According to the most recent rating by Guggenheim, on May 23, the current rating is at Neutral.
• Bausch Health Companies, Inc. BHC stock moved upwards by 3.0% to $22.95. The most recent rating by H.C. Wainwright, on August 07, is at Buy, with a price target of $54.00.
• Genmab, Inc. GMAB stock surged 2.5% to $19.62. The market cap stands at $11.9 billion. According to the most recent rating by Morgan Stanley, on August 12, the current rating is at Overweight.
• CannTrust Holdings, Inc. CTST stock rose 2.4% to $2.35. The market cap stands at $320.7 million.
• Histogenics, Inc. HSGX stock increased by 2.0% to $0.20. The market cap stands at $52.8 million.

Losers

• Guardion Health Sciences, Inc. GHSI shares decreased by 41.2% to $0.35 during Tuesday's pre-market session. The market value of their outstanding shares is at $23.8 million.
• Heat Biologics, Inc. HTBX shares fell 4.9% to $0.56. The market value of their outstanding shares is at $23.3 million. The most recent rating by Brookline Capital, on July 30, is at Buy, with a price target of $8.00.
• Sienna Biopharmaceuticals, Inc. SNNA stock decreased by 4.0% to $0.96. The market value of their outstanding shares is at $346.5 million.
• Clovis Oncology, Inc. CLVS stock plummeted 3.2% to $5.49. The most recent rating by Bank of America, on August 13, is at Neutral, with a price target of $7.00.
• Cancer Genetics, Inc. CGIX shares fell 2.8% to $0.13. The market cap seems to be at $7.9 million.
• Interpace Diagnostics Gr, Inc. IDXG stock plummeted 2.3% to $0.81. The market cap stands at $32.1 million.